Technique for Placing the Guide Screw
All instruments are sterilized before the procedure and sterile small-animal surgical techniques are used. The mice are allowed to feed until the time of surgery. Animals are anesthetized by intraperitoneal injection with ketamine/xylazine solution (200 mg ketamine and 20 mg xylazine in 17 ml of saline) at a dosage of 0.15 mg/10 g body weight.
Step 1: Identification of Implantation Site. The animal's head is stabilized manually by holding it with one finger behind the interaural line and another finger just behind the intercanthal line; a stereotactic frame is not used. The skin is prepared with povidone iodine solution and then a 2-to 3-mm-long incision is made just to the right of midline and anterior to the interaural line so that the coronal and sagittal sutures can be identified; the bregma is located ( Fig. 2 upper left) . The guide-screw entry site is marked at a point 2.5 mm lateral and 1 mm anterior to the bregma. This point is chosen because it is located directly above the caudate nucleus, which has been shown to be a highly reliable intracranial site for tumor engraftment. 5, 6 Step 2: Drill Hole Placement. Using a small hand-controlled twist drill that is 1 mm in diameter (Plastics One), a drill hole is made in the animal's skull at the entry point ( Fig. 2 upper right) . Care is taken to avoid widening the hole beyond the bit diameter because subsequent placement of the guide screw requires that the hole be exactly the size of the screw. The drill bit penetrates the dura and thereby opens it.
Step 3: Placement of the Screw Guide. The sterilized guide screw is rotated into the hole until it is flush with the skull (Fig. 2 lower left). This maneuver is facilitated by using a specially devised screwdriver (Plastics One) that holds the guide screw. The screw is threaded into the hole and secured with several firm twists. The top of the screw is approximately 1 mm above the skull surface and its shaft protrudes through the dura and into the brain surface.
Step 4: Placement of the Stylet. The central hole of the guide screw is closed by placing a cross-shaped stylet inside it ( Fig. 2  lower right) . This prevents tissue from growing into the guidescrew hole. The wound may be closed with No. 4-0 vicryl sutures, although as experience is gained the incisions frequently become small enough that no suturing of the skin is required. The mice are kept warm until they recover from anesthesia. Animals are allowed to move freely until the time of cell implantation.
Technique for Engrafting Human Glioma Cells
Because the guide screw is in place and the point of entry is fixed, implantation of cells can take place at any time.
Step 1: Cell Preparation. On the day of cell implantation, cultured human glioma cells are harvested and resuspended in Ca ++ / Mg ++ -free PBS at the desired concentration. We usually inject a 3-l suspension of between 5 ϫ 10 5 and 10 6 cells into each animal, depending on the cell type. Therefore, for most cell lines the appropriate cell concentration is between 1.3 ϫ 10 5 cells/l and 2 ϫ 10 5 cells/l. The cells are kept on ice until implantation.
Step 2: Cell Injection With Hamilton Syringe. Mice with the guide screw in place are reanesthetized as described earlier. The guide screw is cleaned with povidone iodine, the animal's head is held manually, and the stylet is removed using a fine forceps. The 3-l cell suspension is drawn up into the cuffed Hamilton syringe. A freehand technique is then used to implant cultured cells (Fig.  3) . The needle of the Hamilton syringe is slowly lowered into the central hole of the guide screw until the cuff rests on the screw surface. The cell suspension is slowly injected (typically over 5 minutes) into the mouse's brain. Based on the entry point of the guide screw and the depth of needle penetration, it is certain that the cells are injected into the caudate nucleus. 5, 6, 9 After the entire volume of the cell suspension is injected, the needle is manually removed. The stylet is repositioned in the screw hole by using a fine forceps to close the system. The mice are kept warm until they recover from anesthesia and are allowed to move around freely until the time of intratumoral injection of novel therapeutic material. In the interim the injected tumor cells proliferate and establish themselves as intraparenchymal xenografts.
Technique for Intratumoral Therapeutic Injection
The technique of intratumoral injection mimics the technique of tumor cell implantation, except that a therapeutic agent is delivered into the established xenograft. The guide screw ensures that the tip of the needle penetrates the xenograft and that as a result the therapeutic material is delivered into the tumor.
Step 1: Preparation of Viral Vector. On the day of intratumoral injection with a gene therapy vector, the material is prepared and resuspended in the desired volume of vehicle. These parameters will depend on the therapy being tested.
Step 2: Injection of Therapeutic Agent With Hamilton Syringe. Previously engrafted mice are reanesthetized, the guide screw is cleaned with povidone iodine solution, and the stylet is removed. The gene vector suspension is drawn into the Hamilton syringe; then, using a freehand technique, the syringe is slowly lowered into the central hole of the guide screw until the cuff rests on the screw surface. This positions the tip of the needle within the xenograft (Fig. 3) , into which the vector suspension is injected over a period of 5 minutes. The needle is slowly removed and a new stylet is secured in position. Animals are allowed to recover and the effects of the therapy are observed.
Experimental Studies

Human Glioma Cell Cultures
For xenograft formation, the human glioma cell line U87MG was used. Cells were maintained in Dulbecco's modified Eagle's medium supplemented with 10% bovine serum and incubated at 37˚C in a humidified atmosphere containing 5% carbon dioxide/95% air. On the day of implantation, monolayer cell cultures were harvested using a 0.05% trypsin/ethylenediamine tetraacetic acid solution. Cells were counted, resuspended in 3 l of PBS at the desired concentration, and maintained on ice until inoculation.
Animal Hosts
Forty-five female 4-to-6-week-old nude mice (strain nu/nu; Harlan Sprague-Dawley, Inc., Indianapolis, IN), each weighing 20 to 30 g, were used to test the implantable guide-screw system. All procedures were performed in accordance with regulations of the Animal Care and Use Committee of the University of Texas M. D. Anderson Cancer Center. The mice were housed in groups of five in cages within a standardized barrier facility and maintained on a 12-hour day/night cycle at 23˚C. Animals were given free access to laboratory chow and water.
Experimental Protocol and Groups
All animals underwent implantation of guide screws and after 1 to 2 weeks they were divided into three groups (Table 1) . For animals in Group 1 (23 mice), 10 6 U87MG glioma cells were injected and the animals were killed 5 days later to verify the presence of a xenograft. For animals in Group 2 (15 mice), 10 6 U87MG glioma cells were implanted and 3 days later adenovirus vector containing the ␤-galactosidase gene (Ad-␤-Gal) was injected intratumorally. These animals were then killed after 2 days to verify the accuracy of intratumoral injections. For animals in Group 3 (six mice), survival was determined after inoculation of 5 ϫ 10 5 U87MG glioma cells.
Tissue Collection and Processing
The animals in Group 1 were anesthetized with ketamine/xylazine as described earlier and killed by intracardiac perfusion with saline (75 ml) followed by a 10% formalin/0.1 M phosphate solution. The brains were removed and placed in a 30% sucrose/10%
FIG. 2. Artist's drawings showing the method of implanting the guide screw. Upper Left:
The skin is incised and the coordinates for the point of screw implantation are visualized on the skull. This point is directly over the caudate nucleus. Upper Right: A small drill hole is made using a hand-held drill bit, which creates a hole designed to accept the guide screw. Lower Left: The guide screw is held in a specially designed screw driver and rotated into the drill hole with firm turns until it is flush with the skull surface. The guide screw penetrates the dura and the surface of the brain. Lower Right: A stylet is positioned in the screw to keep the system closed.
formalin solution until saturation was achieved; a block was cut from each brain around the site of the xenograft and embedded in paraffin. Every 10th microtome section was mounted, stained with hematoxylin and eosin, and evaluated using light microscopy.
The Ad-␤-Gal Construct and X-Gal Staining
To test our ability to perform intratumoral injections consistently for gene therapy by using the guide-screw system, Ad-␤-Gal was used as a reporter for gene transfer. The construction and generation of Ad-␤-Gal has been described previously. 2 Briefly, the E1 region of Type 5 adenovirus was replaced with the ␤-galactosidase gene. 
Results
Guide-Screw Implantation
Successful implantation of the guide screw was achieved in 44 (98%) of 45 mice. The first animal died of an intracranial hemorrhage because the screw was placed too close to the sagittal sinus. Correction of the screw placement coordinates resulted in the remaining 44 animals surviving the procedure. One animal developed a superficial skin infection that was opened and irrigated, with no adverse sequelae. There were no deaths related to anesthetic agents, skull fractures, or injuries to the adjacent soft tissues (for example, eye injury).
Tumor Production and Morphological Characteristics
To assess whether the guide-screw technique allowed for reproducible engraftment of cells within the caudate nucleus, 38 mice were inoculated with U87MG cells and killed 5 days later (Groups 1 and 2 ). There were no hemorrhages or infections associated with cell implantation. In 37 (97%) of these 38 animals, xenografts were evident within the caudate nucleus based on results of histological studies (Fig. 4) . At the time the mice died, the tumors ranged from 2 to 3.5 mm in diameter, and they were spherical. One tumor extended into the subarachnoid space. No animal had evidence of hydrocephalus or tumor within the ventricles.
Intratumoral Injection of Ad-␤-Gal
To determine whether injections into the center of an established tumor mass could be reproducibly achieved with the guide-screw system, Ad-␤-Gal was injected via the guide screw 3 days after cell engraftment, and the animals were killed 2 days later. Their brains were removed and processed for X-Gal staining (Group 2). In all 15 animals cells were stained within the central region of the tumor. Specimens also contained transfected cells at the tumor/cerebral tissue border (Fig. 5) . It appeared that the needle used to deliver therapeutic agents resided in the center of the tumor in all cases. Consistent with other studies in which stereotactic techniques were used, 2, 3 30 to 40% of the cells at the center of the tumor appeared to express the ␤-galactosidase gene product. Localization of staining at the edge of similar tumors was also observed by Viola, et al. 11 
Survival of Nude Mice After Cell Engraftment
For an animal model to be of use in assessing the effi- cacy of various treatments, it is necessary that engrafted animals have a uniform survival time that is indicative of a reproducible tumor growth rate. Figure 6 shows the survival times of six mice engrafted with 5 ϫ 10 5 U87MG cells by using the guide-screw technique (Group 3). This lower number of cells was used because of the large size of the tumors seen at 5 days when 10 6 cells were inoculated. Mice were killed when they developed characteristic symptoms, including hunched posturing, conjunctival injection, hemiparesis, and weight loss. The median survival time was 34 days, with a range of 28 to 35 days. Thus, the guide-screw system allows for reproducible establishment of uniformly sized xenografts within nude mice.
Discussion
The new guide-screw system described in this study developed from the need to engraft human glioma cells intracranially in nude mice in a rapid and reproducible manner and to have the option of injecting gene therapy agents into the established xenografts. Techniques that rely on positioning the mouse in a stereotactic frame are the most common methods used today to engraft tumor cells in nude mice and to treat these grafts with intratumoral therapies.
A major advantage of the guide screw is that it does not require a stereotactic frame. Although Kobayashi, et al., 6 recommended using stereotactic methods in rats, in smaller animals such as nude mice, positioning the animal correctly in the stereotactic frame can be cumbersome and time consuming, even after significant expertise is achieved. The goal of stereotactic methods is to localize a particular brain site. This goal is achieved with our system by correctly positioning the guide screw, which fixes the injection site and thereby mimics stereotactic techniques without the necessity of positioning the animal in the stereotactic frame. The key to our technique is that the guide screw rests firmly on the surface of the skull and thereby fixes the vertical orientation of the injection needle in the correct plane. In other words, the angle of injection is
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Guide-screw system in small animals maintained by tightly securing the screw to the skull surface, because the central canal of the screw is finely machined so that the injection needle is unable to wobble. When the bregma is used as the primary landmark, the screw can be accurately positioned over the caudate nucleus without using a stereotactic headframe. 5 Placing a cuff on the Hamilton syringe needle fixes the depth of injection, again obviating the need for the stereotactic frame.
Our results in 38 animals demonstrated that the "tumor take" was approximately 97%, and all tumors were located in the caudate nucleus.
Another major advantage of the proposed system is that the guide screws can be inserted into animals at any time before cell implantation. Animals with guide screws in place can be held in reserve even before the experimental design has been determined. We implanted the system in animals up to 1 month before engrafting tumor cells. Moreover, on the day of engraftment, more animals can be implanted with tumor cells by using the guide-screw system than by using stereotactic methods. As we gained experience with the guide-screw system, cells were being implanted in 10 to 12 animals per hour, compared with three per hour when using stereotactic methods. The reason for this difference in time is that the animal does not have to be positioned in the stereotactic frame and that a freehand injection technique can be used. Because more animals can be implanted with the same batch of cells, experimental variation resulting from harvesting the cells at different times is eliminated. In addition, in contrast with experiments conducted using a stereotactic frame, little time elapses between inoculation of the first and last animals when the guide screw is used. Therefore, less variation in cell viability at the time of engrafting occurs in the experiment.
Probably the most significant advantage of the guidescrew system is that it is ideal for delivery of therapeutic vectors directly into the intracranial xenografts, as is needed in gene transfer strategies. [1] [2] [3] [4] 7, 8 The visualization necessary to ensure intratumoral delivery is obviously not possible with intracranial models because the skull obscures it. In our research, stereotactic methods for intratumoral treatments present several problems. First, inaccuracies caused by repositioning the animal in the stereotactic frame occur because the tumor cell implantation and gene therapy injection by necessity take place at different times. In particular, slight variations in the head position cause large errors in the trajectory of the needle, especially in small animals such as nude mice. Second, the burr hole that is made at the time of cell implantation has usually closed by the time of therapeutic injection, so that it is often questionable whether the site of the therapeutic injection is exactly the same as the site of the cell inoculation. Third, the stereotactic technique is time consuming as well. The guide-screw system obviates the need for repositioning the mouse in the stereotactic frame and, therefore, eliminates any repositioning problems. The trajectory of the needle is the same for all injections. Fourth, the guide screw is permanent and, therefore, prevents healing of the skull. Last, intratumoral injections can be performed quite rapidly, primarily because freehand injections are used. Our studies with Ad-␤-Gal as a reporter of gene transfection have demonstrated that the technique effectively delivers intratumoral therapies.
Conclusions
The guide-screw system provides the accuracy of stereotactic localization without the use of a stereotactic frame. It is safe, reproducible, and allows a large number of animals to be engrafted and/or treated intratumorally in a short period of time.
